Drug Database
A03AB02 glycopyrronium bromide
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Assicco 1mg Tablets
- POM Assicco 2mg Tablets
- POM Glycopyrronium Bromide 1 mg/5 ml Oral Solution
- POM Glycopyrronium bromide 1mg tablets
- POM Glycopyrronium bromide 1mg Tablets
- POM Glycopyrronium Bromide 1mg tablets
- POM Glycopyrronium Bromide 1mg Tablets
- POM Glycopyrronium bromide 1mg/5ml Oral Solution
- POM Glycopyrronium Bromide 1mg/5ml Oral Solution
- POM Glycopyrronium bromide 1mg/5ml Oral Solution-Strandhaven Limited t/a Somex Pharma
- POM Glycopyrronium Bromide 200 micrograms/ml Solution for Injection
- POM Glycopyrronium Bromide 200 micrograms/ml Solution for Injection
- POM Glycopyrronium bromide 2mg tablets
- POM Glycopyrronium bromide 2mg Tablets
- POM Glycopyrronium Bromide 2mg tablets
- POM Glycopyrronium Bromide 2mg Tablets
- POM Glycopyrronium bromide 3g, 5g, 10g Powder for Solution for Iontophoresis
- POM Glycopyrronium Bromide and Neostigmine Metilsulfate 0.5mg/2.5mg per ml Solution for Injection (Robinul-Neostigmine 0.5mg/2.5mg per ml Solution for Injection)
- POM Sialanar 320 micrograms/ml Glycopyrronium (400 micrograms/ml Glycopyrronium Bromide) Oral Solution
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).